Game Day to Support Boston Children’s Hospital for a Day of Fun

November 5, 2020

Game Day, is a virtual gaming event that will bring together families and gamers alike for a day of fun and fundraising. Boston Children’s Hospital is working with Extra Life to host Game Day.

On Saturday, November 7, participants will be encouraged to gather family or friends virtually to play anything from their favorite board game to online video games – all in the spirit of raising funds to support patient care and lifesaving research at Boston Children’s, the nation’s top pediatric hospital. Participants can also follow along with other gamers as games are streamed on Twitch.

To participate, players will sign-up at extra-life.org and choose Boston Children’s Hospital, play their games and donate what they can to the hospital. Money raised through the event will benefit many areas of Boston Children’s Hospital, through its Every Child Fund. This fund fuels promising research and vital family services not covered by insurance. Every penny raised goes directly to helping kids.

Extra Life unites thousands of gamers around the world in support of local Children’s Miracle Network Hospitals. Since its inception in 2008, Extra Life has raised more than $70 million for sick and injured kids.

“For twenty years, the Extra Life program has been connecting gamers all over the country to support families at Boston Children’s Hospital,” said Erin Keefe, development coordinator, Boston Children’s Hospital Trust. “There are over 1,700 gamers who are committed to Extra Life throughout the year leading up to our big national Game Day in November. Last year alone, our Extra Life program raised over $400K to help patients and families at Boston Children’s.”

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”